2. Katey Ruppert Section 003 13 February 2012 Merck & Co., Inc.

3. History of Merck 1891: Founded in U.S. from parent company E. Merck (German) 1899: First Merck Manual (guide for physicians and pharmacists) 1944: Discovery of streptomycin, succeed in synthesis of cortisone 1953: Merck & Co., Inc. merge with Sharp & Dohme 1955: Schering-Plough Foundation established 1957: Merck Company Foundation 1963: First measles vaccine 1967: First mumps vaccine 2000: Merck and Schering-Plough join in U.S. to develop and market new prescriptions 2009: Merck and Schering-Plough combine – second largest pharmaceutical company in the world, according to market share Headquarters: Whitehouse Station, NJ Katey Ruppert, 003

4. Merck Products Vaccines Gardasil Afluria Zostavax Proquad M-M-R II Prescription Medication Clarinex Fosamax Nasonex Nuvaring Pepcid Singulair Consumer Products Afrin Coppertone Dr. Scholl’s Lotrimin MiraLax Zegerid OTC Animal Health Vaccines for: Companion animals, ruminants, equine, pigs and poultry Pharmaceuticals, such as: Anti-infectives, anti-inflammatories, anti-parasitics, endocrines, vet specialties, vitamins and minerals Katey Ruppert, 003

5. Merck’s Competitors AstraZenecaAventisBayer AGBristol-Myers Squibb CompanyJohnson & JohnsonPfizer Inc. Katey Ruppert, 003

6. Stock Trend: 2 Year Period Katey Ruppert, 003

7. Future Projections 2011: Merck’s patent protection on top-selling asthma drug Singulair ran out Set back company’s profits Forecast for 2012/2013: Merck expected to gain approval for 5 new products Drugs for problems with insomnia and osteoporosis, as well as vaccine against cancer-causing virus New drugs are expected to help increase productivity and profits Katey Ruppert, 003

8. Top Executives Kenneth Frazier: Chariman, CEO, and President of Global Human Health Bruce Kuhlik: Executive Vice President and General Counsel Peter Kim: Executive Vice President and President of Merck Research Laboratories Celia Colbert: Senior Vice President and Assistant General Counsel Peter Kellogg: Chief Financial Officer and Executive Vice President Katey Ruppert, 003

9. Thank you! Any Questions? Thank you! Any Questions? Katey Ruppert, 003